For research teamsHelp me find a study
Back to all studies
CompletedEUCTR 2018-003825-27

A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

SchizophreniaDrugFrom 18 Years to 55 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What the source confirms

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

What should you check before joining?

Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View the historical EU CTR record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: November 15, 2018
Recruitment status
Completed
Enrollment listed in the registry
195
Sponsor
Biogen Idec Research Limited
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, United Kingdom, Germany, ...
Age range
From 18 Years to 55 Years
Official registry ID
EUCTR 2018-003825-27
Official title
A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

Check recruitment and locations

EU CTR and ClinicalTrials.gov records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.

Recruitment status comes from the linked ClinicalTrials.gov record. Both registries list the identifiers for the same study.

View the historical EU CTR record (opens in a new tab)View the current ClinicalTrials.gov record (opens in a new tab)
Historical EU CTR country statuses

UK records in EU CTR have not been updated since 1 January 2021. An old ongoing status does not confirm current recruitment.

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Germany · 4 sites
  • Zentrum für klinische Forschung Dr. med. I. Schöll
    Bad Homburg, Hesse
    Site status: Not listed — confirm with the team
  • Clinic for Psychiatrie
    Frankfurt am Main, Hesse
    Site status: Not listed — confirm with the team
  • Universitätsmedizin Göttingen, Klinik für Psychiatrie und Psychotherapie
    Westerstede, Lower Saxony
    Site status: Not listed — confirm with the team
  • Dpt of Psychiatry and Psychotherapy, University of Leipzig
    Leipzig, Saxony
    Site status: Not listed — confirm with the team
Japan · 9 sites
  • Research Site
    Anan-shi
    Site status: Not listed — confirm with the team
  • Research Site
    Ichikawa-shi
    Site status: Not listed — confirm with the team
  • Research Site
    Kashihara-shi
    Site status: Not listed — confirm with the team
  • Research Site
    Kawasaki-shi
    Site status: Not listed — confirm with the team
  • Research Site
    Kita-gun
    Site status: Not listed — confirm with the team
  • Research Site
    Kodaira-shi
    Site status: Not listed — confirm with the team
  • Research Site
    Kumagaya-shi
    Site status: Not listed — confirm with the team
  • Research Site
    Takasaki-shi
    Site status: Not listed — confirm with the team
  • Research Site
    Yokosuka-shi
    Site status: Not listed — confirm with the team
Spain · 7 sites
  • Hospital Universitario Marques Valdecilla
    Santander, Cantabria
    Site status: Not listed — confirm with the team
  • Research Site
    Majadahonda, Madrid
    Site status: Not listed — confirm with the team
  • Research Site
    Oviedo, Principality of Asturias
    Site status: Not listed — confirm with the team
  • Hospital Clinic de Barcelona
    Barcelona
    Site status: Not listed — confirm with the team
  • Hospital Universitario 12 de Octubre
    Madrid
    Site status: Not listed — confirm with the team
  • Unidad Neurociencias CS San Juan
    Salamanca
    Site status: Not listed — confirm with the team
  • Research Site
    Seville
    Site status: Not listed — confirm with the team
United Kingdom · 3 sites
  • Oxford Health NHS Foundation Trust
    Oxford, Oxfordshire
    Site status: Not listed — confirm with the team
  • Abraham Cowley Unit
    Lyne, Surrey
    Site status: Not listed — confirm with the team
  • Research Site
    London
    Site status: Not listed — confirm with the team
United States · 37 sites
  • Pillar Clinical Research, LLC
    Bentonville, Arkansas
    Site status: Not listed — confirm with the team
  • ProScience Research Group
    Culver City, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network, LLC
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • Synergy San Diego
    Lemon Grove, California
    Site status: Not listed — confirm with the team
  • Research Site
    Long Beach, California
    Site status: Not listed — confirm with the team
  • Catalina Research Institute, LLC
    Montclair, California
    Site status: Not listed — confirm with the team
  • Excell Research
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Research Site
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • CNRI - San Diego, LLC
    San Diego, California
    Site status: Not listed — confirm with the team
  • Artemis Institute for Clinical Research
    San Diego, California
    Site status: Not listed — confirm with the team
  • Research Site
    San Diego, California
    Site status: Not listed — confirm with the team
  • Research Site
    San Rafael, California
    Site status: Not listed — confirm with the team
  • Research Site
    Torrance, California
    Site status: Not listed — confirm with the team
  • Yale University, Department of Psychiatry
    New Haven, Connecticut
    Site status: Not listed — confirm with the team
  • Research Site
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Premier Clinical Research Institute, Inc.
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Stedman Clinical Trials
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Augusta University
    Augusta, Georgia
    Site status: Not listed — confirm with the team
  • Research Site
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Research Site
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • Alexian Brothers Hospital Network
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Southern Illinois University, School of Medicine
    Springfield, Illinois
    Site status: Not listed — confirm with the team
  • Research Site
    Gaithersburg, Maryland
    Site status: Not listed — confirm with the team
  • Cherry Health
    Grand Rapids, Michigan
    Site status: Not listed — confirm with the team
  • Research Site
    Flowood, Mississippi
    Site status: Not listed — confirm with the team
  • Research Site
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • St. Louis Clinical Trials, LC
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Hassman Research Institute
    Berlin, New Jersey
    Site status: Not listed — confirm with the team
  • UB Department Psychiatry
    Buffalo, New York
    Site status: Not listed — confirm with the team
  • Neurobehavioral Research, Inc.
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • The Ohio State University Department of Psychiatry
    Columbus, Ohio
    Site status: Not listed — confirm with the team
  • Research Site
    North Canton, Ohio
    Site status: Not listed — confirm with the team
  • Research Site
    Richardson, Texas
    Site status: Not listed — confirm with the team
  • The University of Texas Health Science Center at San Antonio
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    Kirkland, Washington
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: EUCTR 2018-003825-27. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What does the official source confirm?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Is this study recruiting?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

How can I check the participation requirements?

Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.